메뉴 건너뛰기
Neurology
Volumn 82, Issue 1, 2014, Pages 11-12
A call for "negative" outcome studies
Author keywords

[No Author keywords available]
Indexed keywords

CLINICAL TRIAL (TOPIC); EDITOR; EDITORIAL; HUMAN; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL;
EID: 84892189288     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000438233.78964.77     Document Type: Editorial
Times cited : (1)
References (4)
  • 1
    • 50549085053 scopus 로고    scopus 로고
    • Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D
    • Rodino-Klapac LR, Lee J-S, Mulligan RC, Clark KR, Mendell JR. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D. Neurology 2008;71:240-247.
    • (2008) Neurology , vol.71 , pp. 240-247
    • Rodino-Klapac, L.R.1    Lee, J.-S.2    Mulligan, R.C.3    Clark, K.R.4    Mendell, J.R.5
  • 2
    • 84867302438 scopus 로고    scopus 로고
    • A call for transparent reporting to optimize the predictive value of preclinical research
    • Landis SC, Amaram SG, Asadullah K, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012;490:187-191.
    • (2012) Nature , vol.490 , pp. 187-191
    • Landis, S.C.1    Amaram, S.G.2    Asadullah, K.3
  • 3
    • 84876247951 scopus 로고    scopus 로고
    • Should clinicians care about preclinical animal research?
    • Silberberg SD. Should clinicians care about preclinical animal research? Neurology 2013;80:1072-1073.
    • (2013) Neurology , vol.80 , pp. 1072-1073
    • Silberberg, S.D.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.